Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Smart move by TLT management...

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Jul 09, 2024 2:25pm

253 Views

Post# 36124798

RE:RE:RE:RE:RE:RE:RE:RE:Smart move by TLT management...

The reason they set the PP at $10 million is that they had hoped to land an investor whose minimum investment amount was $10 million. They had to set it that high in case they did get a committment.from them. How great the probability of landing this investor was when they applied for the PP is unknown but they needed to set it at 10 just in case. This investor did not commit in time for this round. Why not is the question. Lack of trust in management?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale